Primary outcome measure | |
Proportion of patients prescribed an antibiotic in each arm by day 28 | |
Secondary outcome measures | |
Clinical outcomes | |
By day 7 | |
Proportion of patients with clinical failure, defined as: • admission to hospital OR • death OR • absence of amelioration or worsening of relevant symptoms (fever and/or dyspnoea) | |
By day 28 | |
Proportion of patients with an adverse outcome, defined as: • admission to hospital OR • death OR complications due to LRTI (persistence of pneumonia, lung abscess, lung effusion, empyema or sepsis) | |
Duration of restricted daily activities due to a respiratory tract infection | |
Duration of the episode (defined by the total daily symptom score) | |
Number of medical visits for the episode of LRTI | |
Number of days with side effects related to antibiotics | |
Consultation process outcomes | |
• Time spent by the patient in the practice, time required for the whole consultation • Patient satisfaction with diagnostic process and consultation outcome • Quality of the ultrasound images and of their interpretation • Provider adhesion, level of trust and perceived usefulness of the algorithm recommendation • Identification of barriers and facilitators to the implementation of UltraPro algorithm in primary care | |
Economic outcomes | |
Cost / effectiveness ratio |